KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Receivables - Net (2016 - 2025)

Sarepta Therapeutics has reported Receivables - Net over the past 16 years, most recently at $398.2 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 33.85% year-over-year to $398.2 million; the TTM value through Dec 2025 reached $398.2 million, down 33.85%, while the annual FY2025 figure was $398.2 million, 33.85% down from the prior year.
  • Receivables - Net for Q4 2025 was $398.2 million at Sarepta Therapeutics, up from $395.7 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $659.4 million in Q1 2025 and troughed at $118.2 million in Q1 2021.
  • A 5-year average of $314.1 million and a median of $277.8 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: soared 86.55% in 2023 and later plummeted 33.85% in 2025.
  • Year by year, Receivables - Net stood at $153.0 million in 2021, then soared by 40.27% to $214.6 million in 2022, then soared by 86.55% to $400.3 million in 2023, then soared by 50.37% to $602.0 million in 2024, then plummeted by 33.85% to $398.2 million in 2025.
  • Business Quant data shows Receivables - Net for SRPT at $398.2 million in Q4 2025, $395.7 million in Q3 2025, and $527.3 million in Q2 2025.